Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical erythromycin + zinc acetate vs erythromycin for mild to moderate acne vulgaris
IRCT20120215009014N397Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acne vulgaris comparing Topical erythromycin + zinc acetate with Topical erythromycin (2 arms). Started May 2021; status: completed.
02
Drugs
erythromycinzinc acetate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20120215009014N397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N397.